ViroGates is expanding and has employed yet another two employees; new Global Partner Director and new CFO.

Global Partner Director

As from August 1, Thomas Brydensholt has started as our Global Partner Director. Thomas will be responsible for our indirect sales to the acute care segment through distributors, in territories where we today are not available via a direct sales approach.

Thomas joins us from Getinge, where he most recently headed the Business Development Team in DACH. Before that, he was responsible for the EMEA business strategy for Getinge’s Health Care Division. Thomas’ educational background is an HD in Sales & Marketing from Copenhagen Business School (CBS).


As from October 1, Mark Christian Hvidberg da Silva will start as new CFO of ViroGates. The former CFO, May Britt Dyvelkov will remain with ViroGates in a new position as Vice President of Accounting.

Mark is 29 years old and joins ViroGates from a position as Manager in the management consulting company QVARTZ, where he was heading several client projects within corporate strategy, go-to-market strategy, commercial excellence etc. Mark has previously also worked for Novozymes in Denmark and Nova Founders Capital in Malaysia and the Philippines.

Mark holds an M.Sc. in Economics and Business Administration (International Business) from the Copenhagen Business School.

In ViroGates, Mark will lead a CFO function with focus on executing strategy, reporting and finance, as well as investor relations.

We welcome Thomas and Mark to the ViroGates team and wish them good luck in their new positions!